84 related articles for article (PubMed ID: 23036533)
1. The assessment of thrombotic risk using a predictive model in metastatic cancer patients undergoing first-line therapy.
Kim SY; Burns ZT; Henry DH
Thromb Res; 2012 Dec; 130(6):967-70. PubMed ID: 23036533
[No Abstract] [Full Text] [Related]
2. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
Khorana AA; Dalal M; Lin J; Connolly GC
Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab.
Mochizuki S; Yoshino T; Kojima T; Fuse N; Ikematsu H; Minashi K; Yano T; Tahara M; Kaneko K; Doi T; Koike K; Ohtsu A
Jpn J Clin Oncol; 2010 Oct; 40(10):933-7. PubMed ID: 20494948
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients.
Roselli M; Ferroni P; Portarena I; Riondino S; La Farina F; Formica V; Vergati M; Guadagni F
Thromb Haemost; 2012 Dec; 108(6):1243-5. PubMed ID: 23052961
[No Abstract] [Full Text] [Related]
7. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
[TBL] [Abstract][Full Text] [Related]
8. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
9. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
10. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
11. D-dimer before chemotherapy might predict venous thromboembolism.
Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
[TBL] [Abstract][Full Text] [Related]
12. Acute limb ischemia in cancer patients: should we surgically intervene?
Tsang JS; Naughton PA; O'Donnell J; Wang TT; Moneley DS; Kelly CJ; Leahy AL
Ann Vasc Surg; 2011 Oct; 25(7):954-60. PubMed ID: 21821390
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for thrombosis in cancer patients.
Ashrani AA; Heit JA
Cancer Treat Res; 2009; 148():95-114. PubMed ID: 19377921
[No Abstract] [Full Text] [Related]
14. Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.
Hong J; Han SW; Ham HS; Kim TY; Choi IS; Kim BS; Oh DY; Im SA; Kang GH; Bang YJ; Kim TY
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1323-31. PubMed ID: 20734048
[TBL] [Abstract][Full Text] [Related]
15. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma.
Lekovic D; Miljic P; Mihaljevic B
Thromb Res; 2010 Dec; 126(6):477-80. PubMed ID: 21126629
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience.
Nobili E; Di Cicilia R; Di Battista M; Morselli-Labate AM; Paragona M; Corbelli J; Macchini M; Prandoni P; Biasco G; Brandi G
Pathophysiol Haemost Thromb; 2010; 37(1):30-4. PubMed ID: 20956868
[TBL] [Abstract][Full Text] [Related]
18. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.
Sougioultzis S; Syrios J; Xynos ID; Bovaretos N; Kosmas C; Sarantonis J; Dokou A; Tzivras D; Zografos G; Felekouras E; Papalambros E; Tsavaris N
Eur J Surg Oncol; 2011 Apr; 37(4):312-8. PubMed ID: 21300519
[TBL] [Abstract][Full Text] [Related]
19. An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients.
Ferroni P; Martini F; Portarena I; Grenga I; Riondino S; La Farina F; Laudisi A; Roselli M; Guadagni F
Thromb Haemost; 2011 May; 105(5):931-2. PubMed ID: 21359410
[No Abstract] [Full Text] [Related]
20. Risk stratification for cancer-associated venous thromboembolism.
Connolly GC; Khorana AA
Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
